Clinical Trial

University of Utah PS-IDE: Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysms

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the effects of a physician-modified endovascular graft (PMEG) for juxtarenal aortic aneurysms by collecting data on its performance. Participants in the study will undergo surgery to repair their juxtarenal aortic aneurysm using the PMEG device. After the surgery, participants will attend several follow-up visits to monitor their recovery and the device's effectiveness. These follow-up visits will take place at hospital discharge, then at 1 month, 6 months, 12 months, and once a year for up to 5 years after surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-10.
Status change: Not Yet Recruiting → Recruiting 2026-05-13
Trial Details
NCT Number NCT07065760
Lead Sponsor Cali Johnson
Conditions Juxtarenal Abdominal Aortic Aneurysm
Enrollment 15 participants
Start Date 2025-05-15
Primary Completion 2027-08-01 (estimated)
Study Completion 2032-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-15